in Prior Asbestos Workers using Low-Dose Computed Tomography - - PowerPoint PPT Presentation

in prior asbestos workers using low dose
SMART_READER_LITE
LIVE PREVIEW

in Prior Asbestos Workers using Low-Dose Computed Tomography - - PowerPoint PPT Presentation

Early Diagnosis of Mesothelioma and Lung Cancer in Prior Asbestos Workers using Low-Dose Computed Tomography Cross-sectional views through the chest nodule pleural plaques pleural plaques: reliable marker for asbestos exposure


slide-1
SLIDE 1

Early Diagnosis of Mesothelioma and Lung Cancer in Prior Asbestos Workers using Low-Dose Computed Tomography Cross-sectional views through the chest

slide-2
SLIDE 2

nodule

slide-3
SLIDE 3

pleural plaques

pleural plaques:

  • reliable marker for asbestos exposure
  • indicator of increased risk for malignant mesothelioma
slide-4
SLIDE 4

pleural plaques on CT

slide-5
SLIDE 5

thickness area / volume density calcifications? involved pleura (costal, diaphragmatic, mediastinal) symmetry? fluid? shape (flat or lobulated)

slide-6
SLIDE 6

malignant mesothelioma

slide-7
SLIDE 7

Baseline low-dose CT

no or inconspicuous plaques

  • r

no or non-specific nodules annual repeat no change bi-annual repeat indeterminate nodules

(≥5 mm solid or ≥8 mm non-solid)

  • r

suspicious plaques

lobulated, asymmetric, effusion

6 months f/u no change annual repeat suspicious nodules (≥15 mm)

  • r mass-like plaques

with effusion immediate biopsy

Follow up flow chart

endobronchial nodules 3 months f/u resolved (mucous) annual repeat stable bronchoscopy growth biopsy etc.

slide-8
SLIDE 8

How do I qualify for the study?

To qualify you must be:

  • 30 years of age or older
  • asbestos exposure at least 20 years ago and/or

documented pleural plaques

  • be in general good health
  • no prior cancers (except non-melanotic skin

cancer)

slide-9
SLIDE 9

asbestos CT screening at PMH

  • Study started March 2005
  • 1287 enrolled
  • 13 lung cancers found
  • 8 pleural mesothelioma found
  • 4 peritoneal mesothelioma found
slide-10
SLIDE 10

Lung Car 20% Pleural 13% Peritoneal 6% Other malignancy 61% Distribution of 64 Malignancy in 1287 participates Colon cancer Prostate cancer Kidney Hemopathy Esophageal cancer Bladder cancer Pancreas cancer Liver cancer Breast Duodenal Throat cancer 6 3 7 3 7 4 3 1 1 1 1

Other Malignant 39

slide-11
SLIDE 11